Aggressive multiple sclerosis-is there a role for stem cell transplantation?
Jazyk angličtina Země Německo Médium print
Typ dokumentu časopisecké články, přehledy
- MeSH
- dospělí MeSH
- klinické zkoušky jako téma MeSH
- lidé MeSH
- roztroušená skleróza terapie MeSH
- transplantace hematopoetických kmenových buněk * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Conventional drugs, including disease-modifying drugs, various cytostatic regimens and steroids, are unable to control disease activity in a small group of patients with "malignant" multiple sclerosis (MS). This group of patients could be offered aggressive therapies, such as high-dose immunosuppression followed by haematopoietic stem cell transplant (HSCT). Bone marrow or peripheral blood HSCT has been proposed for the treatment of autoimmune diseases because of its immunosuppressive and immunomodulatory effects, and recapitulation of lymphocyte ontogeny may stabilise or improve the course of MS in some patients. There have been a few small studies conducted using high-dose immunoablation and HSCT. A recent clinical trial of 85 patients treated by HSCT revealed that more than 60% of patients may benefit from this procedure. Due to the perceived risks associated with HSCT, only patients with malignant MS who no longer benefit from more conventional therapies were enrolled. HSCT is thus a justified and feasible treatment in certain patient groups, although transplant-related mortality must be reduced.
Zobrazit více v PubMed
J Clin Invest. 1993 Aug;92(2):765-72 PubMed
Mult Scler. 1999 Feb;5(1):17-21 PubMed
Lancet. 2000 Aug 26;356(9231):701-7 PubMed
Bone Marrow Transplant. 1997 Oct;20(8):631-8 PubMed
Ann Neurol. 1996 Mar;39(3):285-94 PubMed
Lancet. 1998 Nov 7;352(9139):1498-504 PubMed
Haematologica. 1999 Jul;84(7):665-7 PubMed
Bone Marrow Transplant. 1997 Feb;19(4):395-7 PubMed
Neurology. 1993 Apr;43(4):655-61 PubMed
Bone Marrow Transplant. 2000 Mar;25(5):525-31 PubMed
Neurology. 1996 Jun;46(6):1613-9 PubMed
Curr Opin Neurol. 2003 Jun;16(3):299-305 PubMed
Lancet. 1998 Nov 7;352(9139):1491-7 PubMed
Bone Marrow Transplant. 1996 Dec;18(6):1029-34 PubMed
Neurology. 2003 Nov 25;61(10):1332-8 PubMed
Blood. 1998 Apr 1;91(7):2609-16 PubMed
J Neurol. 2002 Aug;249(8):1088-97 PubMed
Blood. 1998 Nov 15;92(10):3505-14 PubMed
N Engl J Med. 1997 Dec 11;337(24):1777-8 PubMed
